Atlas Trials

Regorafenib in Combination With Metronomic Chemotherapies, and Low-dose Aspirin in Metastatic Colorectal Cancer

Clinical trial NCT04534218 · COMPLETED

Trial details

NCT number
NCT04534218
Sponsor
Centre Hospitalier Universitaire de Besancon
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Colo-rectal CancerMetastatic Cancer
Start date
2020-10-16
Primary completion
2023-12-13
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.